Harbour Capital Advisors »

Kailera Therapeutics shares owned by Harbour Capital Advisors

Quarter-by-quarter ownership of Kailera Therapeutics shares owned by Harbour Capital Advisors from 13F filings

Historical chart of Harbour Capital Advisors investment in Kailera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kailera Therapeutics held by Harbour Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kailera Therapeutics by Harbour Capital Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $343k 17k 20.68

More positions owned by Harbour Capital Advisors

Broadcom (AVGO)
Apple (AAPL)
Eli Lilly & Co. (LLY)
Ciena Corp Com New (CIEN)
Lam Research Corp Com New (LRCX)
Ishares Tr Core Msci Eafe (IEFA)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl C (GOOG)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Visa Com Cl A (V)
NVIDIA Corporation (NVDA)
Ishares Tr Rus 1000 Grw Etf (IWF)
Ishares Tr Rus 1000 Val Etf (IWD)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Harbour Capital Advisors

Top funds holding Kailera Therapeutics

Bain Capital Investors
Bain Capital Life Sciences Investors
Rtw Investments
Canada Pension Plan Investment Board
Atlas Venture Life Science Advisors
FMR
BlackRock
Citadel Advisors
Adage Capital Partners GP
Wellington Management Company
Royalty Pharma Sub-Manager
Siren
Vanguard Capital Management
Vanguard Portfolio Management
Geode Capital Management

View all funds holding Kailera Therapeutics